著者: MacklisPaul C, DulmageBrittany, EvansBrady, RosenbachMisha, GudjonssonJohann E, KaffenbergerBenjamin H

原題: Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.

著者: EbrahimNeven A, AbdallaHussein Abdelaziz, YassinNeimat Abd Elhakam, MaghrabiaAya Elsayed, MorsyAmira Ibrahim

原題: Effect of Sofosbuvir on rats' ovaries and the possible protective role of vitamin E: biochemical and immunohistochemical study.

著者: HayesKaleen N, BurkardTheresa, WeilerStefan, TadrousMina, BurdenAndrea M

原題: Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase.

著者: XiaoHong, ChenJun, WangJiangrong, LiJuhua, YangFeia, LuHongzhou

原題: Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.

著者: UrabeAyako, SakamoriRyotaro, TahataYuki, YamadaRyoko, ImaiYasuharu, HagiwaraHideki, TamuraShinji, FukuiHiroyuki, YamadaYukinori, KanekoAkira, HijiokaTaizo, KodamaTakahiro, HikitaHayato, TatsumiTomohide, TakeharaTetsuo

原題: Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients.

著者: Abdel GhaffarTawhida Y, El NaghiSuzan, Abdel GawadManal, HelmySarah, Abdel GhaffarAisha, YousefMedhat, MoafyMohamad

原題: Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4.

著者: YanagidaShota, SatsukaAyano, HayashiSayo, OnoAtsushi, KandaYasunari

原題: Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes.

著者: El-MarakbyMai G, SolaymanMohamed H, SabriNagwa A

原題: Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study.

著者: Ibrahim Mohammed EbidAbdel-Hameed, Ashraf AhmedOsama, Hassan AgwaSara, Mohamed Abdel-MotalebSara, Mohamed ElsawyAmira, HagagRadwa Samir

原題: Safety, efficacy and cost of two direct-acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients.

著者: ElbazTamer, AbdoMahmoud, OmarHeba, HassanEssam A, ZaghloulAmr M, Abdel-SamieeMohamed, MoustafaAhmed, QawzaeAbdallah, GamilMostafa, EsmatGamal

原題: Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection.

著者: De PaceVanessa, MorelliMaria Cristina, RavaioliMatteo, MaggiFabrizio, GalliSilvia, VeroVittoria, ReMaria Carla, CesconMatteo, PistelloMauro

原題: Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases.

著者: El KassasMohamed, AbdeenNermeen, OmranDalia, AlboraieMohamed, SalaheldinMohamed, EltabbakhMohamed, FarghalyRasha, EmadeldeenMohammed, AfifyShimaa, SweedyAhmad, GhalwashAhmed, AbbassAmr, EzzatSameera, TahoonMarwa, ELshazlyHelmy M, HamdyHassan, OmarHeba

原題: Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.

著者: ZamaniFarhad, AjdarkoshHossein, Safarnezhad-TameshkelFahimeh, AzarkeivanAzita, KeyvaniHossein, NaserifarFarshad, VafaeimaneshJamshid

原題: The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors.

著者: ElfertAsem Ahmed, Abd-ElsalamSherief, Abo-AliLobna, EldemerdashTaher, Abou-SaifSabry, ElsabaghHala Mostafa, EbeidAbla, BadawiRehab

原題: Treatment of Hepatitis C Cirrhotic Patients With Directly Acting Antivirals: A Multicenter Study.

著者: HenryZachary, Gonzales ZamoraJose Armando

原題: Evolution of Pretreatment Assessment and Direct Acting Antiviral Regimens in Accordance with Upgrading Guidelines: A Retrospective Study in HIV/HCV Coinfected Patients.

著者: Abo-AmerYousry Esam-Eldin, BadawiRehab, El-AbgeegyMohamed, ElserganyHeba Fadl, MohamedAhmed Abdelhaleem, MostafaSahar Mohamed, AlegailyHatem Samir, SolimanShaimaa, ElnawasanySally, Abd-ElsalamSherief

原題: Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure.

著者: NaveedMariam, AliAmjad, SheikhNadeem, RafiqueShazia, IdreesMuhammad

原題: Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.

著者: ElmekawyH A, BelalF, AbdelazizA E, AbdelkawyK S, AliA A, ElbarbryF

原題: Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers.

著者: MusialikJoanna, KolonkoAureliusz, KwiecieńKatarzyna, OwczarekAleksander J, WięcekAndrzej

原題: Effectiveness and safety of sofosbuvir-based therapy against chronic hepatitis C infection after successful kidney transplantation.

著者: YosryAyman, Gamal EldeenHadeel, MedhatEman, MehrezMai, ZayedNaglaa, ElakelWafaa, AbdelmoniemReham, KaddahMona, AbdelazizAshraf, EsmatGamal, El-SerafyMagdy, DossWahid

原題: Efficacy and safety of sofosbuvir-based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience.

著者: BegovacJosip, KrznarićJuraj, BogdanićNikolina, MočibobLoris, ZekanŠime

原題: Successful treatment of genotype 3 hepatitis C infection in a noncirrhotic HIV infected patient on chronic dialysis with the combination of sofosbuvir and velpatasvir: A case report.

著者: SeoHee Yeon, SeoMyeong-Sook, YoonSun-Young, ChoiJong Wook, KoSoon Young

原題: Full-dose sofosbuvir plus low-dose ribavirin for hepatitis C virus genotype 2-infected patients on hemodialysis.

著者: KarkoutKhaled A, Al SherifSaleema, HusseinQutaiba, AlbawardiAlia, BoobesYousef

原題: Possible acute rejection associated with the use of the new anti-hepatitis C virus medications.

著者: YounasSonia, MukhtarHamid, GoharUmar Farooq, AlsrhaniAbdullah, AlzahraniBadr, JunaidKashaf, QamarMuhammad Usman, EjazHasan

原題: Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients.

著者: HasnainAliya, ShahSabeen, HampejskovaLindsay

原題: Visual symptoms with Sofosbuvir in hepatitis C treatment - a case report from Pakistan.